337 related articles for article (PubMed ID: 21757978)
1. Epidemiology and prevention of hepatitis B virus infection.
Kwon SY; Lee CH
Korean J Hepatol; 2011 Jun; 17(2):87-95. PubMed ID: 21757978
[TBL] [Abstract][Full Text] [Related]
2. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
[TBL] [Abstract][Full Text] [Related]
3. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Vaccines.
Pattyn J; Hendrickx G; Vorsters A; Van Damme P
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S343-S351. PubMed ID: 34590138
[TBL] [Abstract][Full Text] [Related]
5. Global control of hepatitis B virus infection.
Kao JH; Chen DS
Lancet Infect Dis; 2002 Jul; 2(7):395-403. PubMed ID: 12127351
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination.
Romanò L; Paladini S; Galli C; Raimondo G; Pollicino T; Zanetti AR
Hum Vaccin Immunother; 2015; 11(1):53-7. PubMed ID: 25483515
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana.
Baruti K; Lentz K; Anderson M; Ajibola G; Phinius BB; Choga WT; Mbangiwa T; Powis KM; Sebunya T; Blackard JT; Lockman S; Moyo S; Shapiro R; Gaseitsiwe S
PLoS One; 2020; 15(8):e0237252. PubMed ID: 32764801
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination.
Di Lello FA; Blejer J; Alter A; Bartoli S; Vargas F; Ruiz R; Galli C; Blanco S; Gallego S; Fernández R; Martínez AP; Flichman DM
Vaccine; 2020 Mar; 38(12):2678-2682. PubMed ID: 32061386
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
[TBL] [Abstract][Full Text] [Related]
11. The global impact of vaccination against hepatitis B: a historical overview.
Zanetti AR; Van Damme P; Shouval D
Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
Qin Y; Liao P
Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
[TBL] [Abstract][Full Text] [Related]
13. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
14. [Escape mutants of hepatitis B virus].
Jaramillo CM; Navas MC
Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
17. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction.
Kato H; Nakata K; Hamasaki K; Hida D; Ishikawa H; Aritomi T; Nakao K; Kato Y; Yano M; Eguchi K
Vaccine; 1999 Nov; 18(7-8):581-7. PubMed ID: 10547415
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
Wang WL; Shu ZJ; Zhou LX; Zhao YR
Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
